Cornelis Boersma

Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1

Jeroen P. Jansen, Rachael Fleurence, Beth Devine et al. · Value in Health · 2011 · 1K citations · Full text

Nursing, Family Medicine, Counseling +10

Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2

David C. Hoaglin, Neil Hawkins, Jeroen P. Jansen et al. · Value in Health · 2011 · 746 citations · Full text

Family Medicine, Meta-analysis, Psychiatry +8

A Genotype-Guided Strategy for Oral P2Y ₁₂ Inhibitors in Primary PCI

Daniel M.F. Claassens, Gerrit J.A. Vos, Thomas O. Bergmeijer et al. · New England Journal of Medicine · 2019 · 597 citations · Full text

Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)

Jarir At Thobari, Folkert W. Asselbergs, Cornelis Boersma et al. · Clinical Therapeutics · 2006 · 129 citations · Full text

Pharmacoeconomic Analysis, Hemodialysis, Urology +12

Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: Cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands

Cornelis Boersma, Ron T. Gansevoort, Petros Pechlivanoglou et al. · Clinical Therapeutics · 2010 · 53 citations · Full text

Cohort Data, Renal Care, Urology +11